Abstract:
A container for accommodating different injection medicines comprises a first vessel, a second vessel and a partition disk. First vessel is an integral hollow cylinder sandwiched between a pair of intercommunicatable top surface and bottom surface. Second vessel of integral hollow cylinder includes a first holding compartment therein encompassed by an open top surface, a closed bottom surface and a sidewall. Partition disk is padded under the bottom of the first vessel. Partition disk and lower section of first vessel are inserted into upper section of second vessel. Thereby, different injections can be temporarily held in separated compartments respectively without intermixing. When injection administration is required, blending procedure is well hermetically finished in the vial without any syringe needle. Thereby, not only entire blending procedure meets aseptic requirement, but also accidence for the healthcare personnel being pierced by such syringe needle is completely eliminated.

Description:
[0001]    This application claims the benefit of provisional U.S. Patent Application No. 61/272,717, field Oct. 26, 2009. 
     
    
     FIELD OF THE PRESENT INVENTION 
       [0002]    The present invention relates to a container for accommodating different injection medicines, particularly for one that different injections can be temporarily held in separated compartments respectively without any possibility of intermixing. When injection administration is required, blending procedure can be well hermetically finished in the container without any syringe needle serving as blending tool. Thereby, not only the entire blending procedure meets the requirement of aseptic manipulation without any contamination, but also the risk for the healthcare personnel being accidentally pierced by such syringe needle can be completely eliminated. 
       BACKGROUND OF THE INVENTION 
       [0003]    Please refer to  FIGS. 1 through 3 . The injection vial, which is currently used in hospitals and clinics, comprises a vial body  10 , a septum stopper  20  and a crimp cap  30 , wherein said vial body  10 , which is a hollow cylinder, includes a round opening  11 , an interior hollow cavity  12  being able to intercommunicate with the round opening  11 , and a reduced vial neck  13  disposed under the round opening  11 ; said septum stopper  20 , which is made of high density elastic rubber of nontoxic material, includes a planar top round surface  21  and a downward bottom obturating plug  22  such that the outer diameter of the top round surface  21  equals that of the round opening  11  at vial body  10 , and the downward bottom obturating plug  22  can insert into the round opening  11  of vial body  10  in watertight manner; and said crimp cap  30 , which is punched by thin metal foil into round hollowed-out block, has an injection molded plastic safety cover  31  hooded thereon. When prescribed liquid injection medicament R is filled into the interior hollow cavity  12  of vial body  10 , firstly clog the vial body  10  by inserting the bottom obturating plug  22  of the septum stopper  20  into the round opening  11  of the vial body  10 , then cap the crimp cap  30  over the septum stopper  20  such that an inwardly tuck-under thereof closely contact against the reduced vial neck  13  of the vial body  10  so that the prescribed liquid injection medicament R is hermetically contained in the interior hollow cavity  12  without any possibility to leak out of the vial body  10  (as shown in the  FIG. 3 ). 
         [0004]    Taking the hypodermic injection of 5-oxo-prolyl-histidyl-tryptophyl-seryl-tyrosyl-D-leucyl-leucyl-arginyl-N-ethyl-prolinamide monoacetate, which can be injected in the patients of breast cancer and prostate cancer as curing medication by the prescription of the authorized doctors, from the Takeda Pharmaceutical Company Limited (Japan) as example, the delivery package includes a vial for containing light yellow powder Leuprorelin acetate medicament and a glass ampoule for containing medicament solvent. Thereby, the final injection from the mixture of the power Leuprorelin acetate medicament and the medicament solvent can be prepared and blended in the vial body  10  before injecting administration. The preparing and blending steps are depicted as shown in the  FIGS. 4 through 9 . a. Firstly break the neck of the glass ampoulel containing medicament solvent by bending force of the holding fingers (as shown in the  FIG. 4 ); b. Insert and extend syringe needle  3  into the glass ampoulel for sucking the liquid injection medicament R 1  of solvent contained therein into syringe  2  (as shown in the  FIG. 5 ); c. Hook any margin of the safety cover  31  on the vial  10  containing powder Leuprorelin acetate medicament S by the finger(s) and lift up to detach the safety cover  31  off the crimp cap  30  by upwards force (as shown in the  FIG. 6 ); d. Pierce through the septum stopper  20  by the syringe needle  3  and extend it into the interior hollow cavity  12  of vial  10  for squeezing out all the liquid injection medicament R 1  in syringe  2  so that the powder Leuprorelin acetate medicament S can be solved by the solvent of the liquid injection medicament R 1  in the interior hollow cavity  12  (as shown in the  FIG. 7 ); e. Shake the vial  10  after pulling the syringe needle  3  thereat out for several time so as to let the powder Leuprorelin acetate medicament S can be completely solved by the solvent of the liquid injection medicament R 1  to become a final medicated liquid injection M 1  (as shown in the  FIG. 8 ); and f. Finally, re-insert and extend syringe needle  3  into the vial body  10  for sucking out all the medicated liquid injection M 1  into syringe  2  to serve as hypodermic injection medication for the patients (as shown in the  FIG. 9 ). 
         [0005]    Following issues are found in the preparing and blending steps depicted above. A syringe  2  and a syringe needle  3  are used as preparing and blending tools in steps b and d, the risk of contamination and bacteria invasion into the powder Leuprorelin acetate medicament S or the solvent of the liquid injection medicament R 1  may possibly exist depending on the degree of the concentration and dexterity of each healthcare personnel so that any inadvertent operation will be unable to meet the requirement of overall aseptic manipulation. Besides, the healthcare personnel might be accidentally pierced by the syringe needle  3  in steps b and d. 
         [0006]    Moreover, each glass ampoulel containing solvent of liquid injection medicament R 1  and each vial body  10  containing powder Leuprorelin acetate medicament S, which are always fabricated under the different manufacturing schedule by related pharmaceutical factory instead of being fabricated at same time, have each different self-life of their own so that medical organization must carefully recognize each marked self-life thereon by human-eye vision in inventory management. Besides, healthcare personnel must also inspect each marked self-life thereon by human-eye vision before preparing and blending procedure to confirm the validity of medicated liquid injection M 1 , otherwise the medicated liquid injection M 1  may fail to produce medication effect due to expiry of the shelf-life. 
         [0007]    Furthermore, as shown in the  FIGS. 10 through 12 , certain other medicated liquid injection M 2  contains first liquid injection medicament R 2  and second liquid injection medicament R 3 , each of which is filled in each different vial body  10   a  and vial body  10   b  respectively. The blending steps before hypodermic injection administration are depicted below. a. Insert and extend syringe needle  3  into the vial body  10   a  for sucking the first liquid injection medicament R 2  contained therein into syringe  2  (as shown in the  FIG. 10 ); b. Insert and extend syringe needle  3  into the interior hollow cavity  12   b  of vial  10   b  for squeezing out all the first liquid injection medicament R 2  in syringe  2 , next pull the syringe needle  3  thereat out (as shown in the  FIG. 11 ); then shake the vial  10   b  for several time so as to let the first liquid injection medicament R 2  can be completely blended by the second liquid injection medicament R 3  in the interior hollow cavity  12   b  to become a final medicated liquid injection M 2 ; and c. Finally, re-insert and extend syringe needle  3  into the interior hollow cavity  12   b  of vial body  10   b  for sucking out all the medicated liquid injection M 2  into syringe  2  to serve as hypodermic injection medication for the patients (as shown in the  FIG. 12 ). Similarly, following issues are found in the preparing and blending steps depicted above. A syringe  2  and a syringe needle  3  are also used as preparing and blending tools in steps a through c, the healthcare personnel might also be accidentally pierced by the syringe needle  3 , and the risk of contamination and bacteria invasion into the first liquid injection medicament R 2  or the second liquid injection medicament R 3  may possibly exist depending on the degree of the concentration and dexterity of each healthcare personnel too. 
         [0008]    Moreover, other than each of first liquid injection medicament R 2  and second liquid injection medicament R 3  is respectively filled in each of vial body  10   a  and vial body  10   b,  each of opening  11   a  and opening  11   b  on each of interior hollow cavity  12   a  and interior hollow cavity  12   b  needs each of a septum stopper  20  and a crimp cap  30  so that the medical organization are forced to pay extra expense for such an extra septum stopper  20  and crimp cap  30 . In total global calculation, annual extra expense for such an extra septum stopper  20  and crimp cap  30  will be a considerable amount. Besides, the wasted such an extra septum stopper  20  and crimp cap  30  will become an extra burden for environmental protection. 
         [0009]    Accordingly, how to solve all the issues aforesaid becomes an urgent task. Having realized and addressed this fact, the applicant of the present invention has enthusiastically undertaken research and development. Eventually, the expected contrivance of the present invention is successfully worked out. 
       SUMMARY OF THE INVENTION 
       [0010]    The primary object of the present invention is to provide a container for accommodating different injection medicines basically comprising a first vessel, a second vessel and a partition disk, wherein the first vessel is an integral hollow cylinder sandwiched between a pair of top surface and bottom surface, which are able to intercommunicate each other; the second vessel of integral hollow cylinder includes a first holding compartment therein encompassed by an open top surface, a closed bottom surface and a cylindrical sidewall; the partition disk is padded under the bottom of the first vessel; and the partition disk and the lower section of the first vessel are inserted into the upper section of the second vessel. Thereby, by separation of the partition disk, a first liquid or powder injection medicament contained in the second vessel and a second liquid injection medicament contained in the first vessel can be temporarily held in separated compartments respectively without any possibility of intermixing. When injection administration is required, a downwards force is exerted on the first vessel to push the partition disk drop into the second vessel so that the second liquid injection medicament and the first liquid or powder injection medicament can be well blended in the second vessel to become a hypodermic injection medication for the patients. Because the entire blending procedure of the first liquid or powder injection medicament and second liquid injection medicament is proceeded in the hermitical vial without any exposure to ambient air, no possibility of contamination and bacteria invasion will exist. Thus, the entire blending procedure meets the requirement of aseptic manipulation. Besides, because no syringe needle or other sharp article is served as blending tool, the risk for the healthcare personnel being accidentally pierced by such syringe needle or other sharp article can be completely eliminated to ensure a better safety protection. 
         [0011]    The other object of the present invention is to provide a container for accommodating different injection medicines having a partition disk and a safety binding hoop with plural raised lining pads applied to inner surface thereof in a recurring pattern created between the first vessel and second vessel to serve as fixing jointer. Thereby, only single set of conventional septum stopper and crimp cap to required to achieve expected packaging effect after completion for the filling procedure of the first liquid or powder injection medicament and second liquid injection medicament so that not only the demanding quantity of the septum stopper and crimp cap can be economically saved, but also the burden for environmental protection in the wasted septum stopper and crimp cap can be reduced. 
     
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
         [0012]      FIG. 1  is an exploded perspective view for the conventional injection vial. 
           [0013]      FIG. 2  is an assembled schematic view for the conventional injection vial. 
           [0014]      FIG. 3  is a sectional view taken along line  3 - 3  as indicated in  FIG. 2 . 
           [0015]      FIG. 4  is a schematic view for the conventional injection ampoule. 
           [0016]      FIG. 5  is an illustrative schematic view showing the suction of liquid medicament from the conventional injection ampoule by a syringe needle. 
           [0017]      FIG. 6  is an illustrative schematic view showing the opening for the conventional injection vial containing powder medicament. 
           [0018]      FIG. 7  is the first operational schematic view showing the blend of two different medicaments for the conventional injection vial. 
           [0019]      FIG. 8  is the second operational schematic view showing the blend of two different medicaments for the conventional injection vial. 
           [0020]      FIG. 9  is the third operational schematic view showing the blend of two different medicaments for the conventional injection vial. 
           [0021]      FIG. 10  is the fourth operational schematic view showing the blend of two different medicaments for the conventional injection vial. 
           [0022]      FIG. 11  is the fifth operational schematic view showing the blend of two different medicaments for the conventional injection vial. 
           [0023]      FIG. 12  is an illustrative schematic view showing the suction of blended injection mixture from the conventional injection vial by a syringe needle. 
           [0024]      FIG. 13  is an exploded perspective view of a container for accommodating different injection medicines according to a first preferred embodiment of the present invention. 
           [0025]      FIG. 14  is a sectional view taken along line  14 - 14  as indicated in  FIG. 13 . 
           [0026]      FIG. 15  is a sectional view taken along line  15 - 15  as indicated in  FIG. 13 . 
           [0027]      FIG. 16  is a sectional view taken along line  16 - 16  as indicated in  FIG. 13 . 
           [0028]      FIG. 17  is the first operational schematic view showing the assembly and fill medicament for the above first preferred embodiment of the present invention. 
           [0029]      FIG. 18  is the second operational schematic view showing the assembly and fill medicament for the above first preferred embodiment of the present invention. 
           [0030]      FIG. 19  is the third operational schematic view showing the assembly and fill medicament for the above first preferred embodiment of the present invention. 
           [0031]      FIG. 20  is the fourth operational schematic view showing the assembly and fill of two different medicaments for the above first preferred embodiment of the present invention. 
           [0032]      FIG. 21  is the fifth operational schematic view showing the assembly and fill of two different medicaments for the above first preferred embodiment of the present invention. 
           [0033]      FIG. 22  is the first operational schematic view showing the blend and suction of blended injection mixture from the above first preferred embodiment of the present invention. 
           [0034]      FIG. 23  is the second operational schematic view showing the blend and suction of blended injection mixture from the above first preferred embodiment of the present invention. 
           [0035]      FIG. 24  is the third operational schematic view showing the blend and suction of blended injection mixture from the above first preferred embodiment of the present invention. 
           [0036]      FIG. 25  is the fourth operational schematic view showing the blend and suction of blended injection mixture from the above first preferred embodiment of the present invention. 
           [0037]      FIG. 26  is the fifth operational schematic view showing the blend and suction of blended injection mixture from the above first preferred embodiment of the present invention. 
           [0038]      FIG. 27  is a sectional view of the above first preferred embodiment of the present invention having a modified partition disk with an additional annular parapet. 
           [0039]      FIG. 28  is an assembly sectional view showing a modified partition disk with an additional annular sealing ledge in the above first preferred embodiment of the present invention. 
           [0040]      FIG. 29  is a sectional view of the annular sealing ledge for the above first preferred embodiment of the present invention as showing in  FIG. 28 . 
           [0041]      FIG. 30  is a sectional plan view of a second vessel of the container of the present invention. 
           [0042]      FIG. 31  is a sectional view taken along line  31 - 31  as indicated in  FIG. 30 . 
           [0043]      FIG. 32  is an operational schematic sectional view showing blended injection mixture from the above second vessel container of the present invention. 
           [0044]      FIG. 33  is a sectional plan view of a further modified partition disk with additional round dent of the present invention. 
           [0045]      FIG. 34  is an assembly sectional view showing a further modified partition disk with an additional round dent of the present invention. 
           [0046]      FIG. 35  is a disintegrated sectional view showing the container with additional coupling threads in the sixth exemplary embodiment of the present invention. 
           [0047]      FIG. 36  is an assembly sectional view showing a container with additional coupling threads in the sixth exemplary embodiment of the present invention. 
           [0048]      FIG. 37  is a sectional view showing a middle third vessel with a second partition disk being added in a container as the seventh exemplary embodiment of the present invention. 
           [0049]      FIG. 38  is an isolated sectional view showing the second partition disk in a container as the seventh exemplary embodiment of the present invention. 
           [0050]      FIG. 39  is an assembly perspective view showing a middle third vessel with a second partition disk being added in a container as the seventh exemplary embodiment of the present invention. 
           [0051]      FIG. 40  is a cross sectional view taken along line  40 - 40  as indicated in  FIG. 39 . 
       
    
    
     DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS 
       [0052]    Referring to  FIGS. 13 through 21 , a container for accommodating different injection medicines according to a first preferred embodiment of the present invention comprises a first vessel  40 , a second vessel  50  and a partition disk  60 . 
         [0053]    Referring to  FIGS. 13 to 16  and  21 , the first vessel  40  is an integral hollow cylinder, includes a first holding compartment  44  therein encompassed by a top surface  41 , a bottom surface  42  and a cylindrical sidewall  43  such that the first holding compartment  44  is able to intercommunicate with the top surface  41  and bottom surface  42 ; said first holding compartment  44  includes a top opening  45  lying at the top surface  41 , a reduced neck  46  disposed near the top surface  41  on the sidewall  43 , a baffle flange  47  disposed in the middle periphery of the sidewall  43 , and a docking barbed rim  48  disposed in the periphery of the sidewall  43  between the baffle flange  47  and bottom surface  42  so that the top opening  45  can receive the septum stopper  20 , and the reduced neck  46  can be closely contact against by an inwardly tuck-under of the crimp cap  30  so that the top opening  45  of the first holding compartment  44  can be clogged by the septum stopper  20  in watertight manner (as shown in the  FIG. 21 ); 
         [0054]    The second vessel  50  is an integral hollow cylinder, includes a first holding compartment  54  therein encompassed by an open top surface  51 , a closed bottom surface  52  and a cylindrical sidewall  53 ; said second holding compartment  54 , whose inner diameter is slightly bigger than the outer diameter for the sidewall  43  of the first vessel  40 , includes a safety binding hoop  55  with plural raised lining pads applied to inner surface thereof in a recurring pattern disposed over the top surface  51 , a docking fluked lip  56  created in the inner wall thereof near the top surface  51 , a retaining ring mount  57  created in the inner wall thereof about middle section and a latching groove brim  58  created in the central rim of the retaining ring mount  57 ; and 
         [0055]    The partition disk  60  is an integral disk includes a top surface  61  and a bottom surface  62  encompassed by a round sidewall  63 , has a soft silica gel layer  64 , which wraps over the top surface  61  and sidewall  63 , and a latching jut brim  65  outwardly hooped over the soft silica gel layer  64  on the sidewall  63 . 
         [0056]      FIGS. 17 through 21  describe the assembling and filling of the above first preferred embodiment of the present invention in steps as follow: 
         [0057]    Step a: 
         [0058]    First, fill a first liquid injection medicament R 2  into the second holding compartment  54  of second vessel  50  (as shown in the  FIG. 17 ); 
         [0059]    Step b: 
         [0060]    By facing the bottom surface  62  of partition disk  60  towards the bottom surface  52  of second vessel  50 , insert the partition disk  60  into the second holding compartment  54  up to state the sidewall  63  of partition disk  60  being inset in the retaining ring mount  57  of second holding compartment  54  so that the latching jut brim  65  outwardly hooped over the soft silica gel layer  64  on the sidewall  63  of partition disk  60  can mutually contact against the latching groove brim  58  of retaining ring mount  57  in watertight manner to prevent any leakage (as shown in the  FIG. 18 ); 
         [0061]    Step c: 
         [0062]    By aligning the bottom surface  42  of first vessel  40  towards the top surface  51  of second vessel  50 , insert the first vessel  40  into the second holding compartment  54  up to state the bottom surface  42  of first vessel  40  in contact with the top surface  61  of partition disk  60  so that the docking barbed rim  48  on the cylindrical sidewall  43  of first vessel  40  can mutually contact against the docking fluked lip  56  for the second holding compartment  54  of second vessel  50  in closely locked manner (as shown in the  FIG. 19  and left enlarged view of the  FIG. 20 ); 
         [0063]    Step d: 
         [0064]    Next, fill a second liquid injection medicament R 3  into the first holding compartment  44  via the top opening  45  of first vessel  40 ; At this moment, no leakage from first holding compartment  44  will happen because the bottom surface  42  of first vessel  40  is in closely contact with the soft silica gel layer  64  on the top surface  61  of partition disk  60  (as shown in right enlarged view of the  FIG. 20 ); and 
         [0065]    Step e: 
         [0066]    Finally, insert the septum stopper  20  into the top opening  45  for the top surface  41  of first vessel  40 , then cap the crimp cap  30  over the septum stopper  20  to let an inwardly tuck-under thereof closely contact against the reduced neck  46  of the first vessel  40 , thus the entire filling assembly is finished here (as shown in the  FIG. 21 ). 
         [0067]    Please further refer to  FIGS. 22 through 26 . The procedure steps for hypodermic injection of the above first preferred embodiment of the present invention are depicted below: 
         [0068]    Firstly, tear off the safety binding hoop  55  on the top surface  51  of second vessel  50  so that a peripheral space with height equivalent to height of the safety binding hoop  55  forms between the baffle flange  47  on the cylindrical sidewall  43  of first vessel and the top surface  51  of second vessel  50  (as shown in the  FIG. 22 ); 
         [0069]    Secondly, exert downwards force on the crimp cap  30  to cause the bottom surface  42  of first vessel  40  to push the partition disk  60  so that the sidewall  63  of the partition disk  60  is detached off the retaining ring mount  57  on the second holding compartment  54  of second vessel  50  (as shown in the  FIG. 23 ); 
         [0070]    Thirdly, after the partition disk  60  being completely detached off the retaining ring mount  57  and sunk into the second holding compartment  54  of second vessel  50 , the second liquid injection medicament R 3  in the first holding compartment  44  of first vessel  40  will downwardly flow into the second holding compartment  54  to blend with the first liquid injection medicament R 2  therein (as shown in the  FIG. 24 ); 
         [0071]    Fourthly, after the first liquid injection medicament R 2  and second liquid injection medicament R 3  having fully blended each other to become a medicated liquid injection M 2 , hook any margin of the safety cover  31  on the crimp cap  30  by the finger(s) and lift up to detach the safety cover  31  off the crimp cap  30  by upwards force (as shown in the  FIG. 25 ); and 
         [0072]    Finally, pierce through the septum stopper  20  by a syringe needle  3  and extend it into the first holding compartment  44  of first vessel  40  for sucking out all the medicated liquid injection M 2  into syringe  2  to serve as hypodermic injection medication for the patients (as shown in the  FIG. 26 ). 
         [0073]    Comparing the blending procedure of the present invention depicted above to the conventional prior arts described in the section captioned “BACKGROUND OF THE INVENTION”; there are certain advantages as below. In these procedure steps for hypodermic injection of the present invention, the shelf life of first liquid injection medicament R 2  is same as the shelf life of second liquid injection medicament R 3  because they are respectively filled in each second vessel  50  and first vessel  40  on the same day. Thereby, the situation that one of them is expired and the other is not expired will never happen. Accordingly, not only the extra cost loss incurred by the discarded medicaments due to expiry of shelf life can be avoided in the medical organizations, but also the purchasing and adopting intention of the medical organizations in the future will be enhanced. Moreover, because the entire blending procedure of the first liquid injection medicament R 2  and second liquid injection medicament R 3  is proceeded in the hermitical first vessel  40  and second vessel  50  without any exposure to ambient air, no possibility of contamination and bacteria invasion will exist. Thus, the entire blending procedure meets the requirement of aseptic manipulation. Besides, because no syringe needle or other sharp article is served as blending tool, the risk for the healthcare personnel being accidentally pierced by such syringe needle or other sharp article can be completely eliminated to ensure a better safety protection. 
         [0074]    Please refer to  FIG. 27 , which is an illustrative view showing a container for accommodating different injection medicines according to a second exemplary embodiment of the present invention. Wherein said partition disk  60  with an additional annular parapet  66  disposed on the outmost edge of the soft silica gel layer  64  over the top surface  61  of partition disk  60  (as shown in enlarged view of the  FIG. 27 ) so that the partition disk  60  enhances the watertight effect when the bottom surface  42  of first vessel  40  contacts against the soft silica gel layer  64  over the top surface  61  of partition disk  60 . 
         [0075]    Please refer to  FIGS. 28 , and  29 , which are illustrative views showing a container for accommodating different injection medicines according to a third exemplary embodiment of the present invention. Wherein said first vessel  40  having a modified bottom surface  42  with an additional annular sealing ledge  70  cushioned under the bottom surface  42  of first vessel  40  (as shown in the  FIG. 28 ). And said annular sealing ledge  70  is made of non-toxic soft silica gel material which has an annular groove  71  upwardly created around the rim thereof to serve as a receptacle for the bottom surface  42  of first vessel  40  so that the watertight effect of the partition disk  60  is enhanced by the annular sealing ledge  70  when the bottom surface  42  of first vessel  40  contacts against the soft silica gel layer  64  over the top surface  61  of partition disk  60  (as shown in enlarged view of the  FIG. 28 ). 
         [0076]    Please refer to  FIGS. 30 through 32 , which are illustrative views showing a container for accommodating different injection medicines according to a fourth exemplary embodiment of the present invention. The container here includes a modified second holding compartment  54  with additional plural supporting jutties  59  protruded under the retaining ring mount  57  in the second holding compartment  54  of second vessel  50  (as shown in the  FIG. 30 ). The distribution range of the plural supporting jutties  59  is less than one quarter for the circumference of second vessel  50  (as shown in the  FIG. 31 ). The contact points between these plural supporting jutties  59  and the bottom surface  62  function as multiple fulcra for the rocking partition disk  60  (as shown in the  FIG. 32 ) when the bottom surface  42  of first vessel  40  contacts and presses on the top surface  61  of partition disk  60  due to downwards force exerting on the first vessel  40  so that the partition disk  60  will be moved as a rocker to detach off the catching of the retaining ring mount  57 . 
         [0077]    Please refer to  FIGS. 33 , and  34 , which are illustrative views showing a container for accommodating different injection medicines according to a fifth exemplary embodiment of the present invention. The container here includes a modified partition disk  60  with an additional round dent  67  created at the central bottom surface  62  in the partition disk  60  of second vessel  50  (as shown in the  FIG. 33 ). The centrally thinned round dent  67  of the partition disk  60  provides an allowance for inwards constriction to partition disk  60  (as shown in the  FIG. 34 ) when the cylindrical sidewall  63  of partition disk  60  engages on or disengages off the retaining ring mount  57  of second vessel  50  so that an effectively labor-saving operation can be achieved. 
         [0078]    Please refer to  FIGS. 35 , and  36 , which are illustrative views showing a container for accommodating different injection medicines according to a sixth exemplary embodiment of the present invention. The container here includes a modified first vessel  40  with an additional male thread  49  created on the periphery of sidewall  43  in the first vessel  40  (as shown in upper view of the  FIG. 35 ) while a modified second vessel  50  with an additional female thread  541  created on the inner wall of sidewall  53  for the second holding compartment  54  of second vessel  50  (as shown in lower view of the  FIG. 35 ) such that the female thread  541  can be screwed by the male thread  49  in corresponding engagement. The corresponding pair of male thread  49  and female thread  541  provides an easy docking means first vessel  40  and second vessel  50  (as shown in the  FIG. 36 ) when the first liquid injection medicament R 2  blends with the second liquid injection medicament R 3  so that an effectively labor-saving docking operation can be achieved. 
         [0079]    Please refer to  FIGS. 37 through 40 , which are illustrative views showing a container for accommodating different injection medicines according to a seventh exemplary embodiment of the present invention. The container here includes an additional middle third vessel  80  and a second partition disk  90 , wherein said middle third vessel  80 , which is an integral hollow cylinder, includes a third holding compartment  84  therein encompassed by an open top surface  81 , a bottom surface  82  and a cylindrical sidewall  83  such that the third holding compartment  84  is able to intercommunicate with the top surface  81  and bottom surface  82 ; the (third holding compartment  84 ), whose inner diameter thereof is slightly bigger than the outer diameter of the cylindrical sidewall  43  in the first vessel  40  while whose outer diameter thereof is slightly less than the inner diameter of the second holding compartment  54  in the second vessel  50 , includes a safety binding hoop  85  with plural raised lining pads applied to inner surface thereof in a recurring pattern disposed over the top surface  81 , a docking fluked lip  86  created in the inner wall thereof near the top surface  81 , a retaining ring mount  87  created in the inner wall thereof about middle section and a latching groove brim  871  created in the central rim of the retaining ring mount  87 , a baffle flange  88  disposed in the middle periphery of the sidewall  83 , and a docking barbed rim  89  disposed in the periphery of the sidewall  83  between the baffle flange  88  and bottom surface  82 ; and said second partition disk  90 , which is an integral disk includes a top surface  91  and a bottom surface  92  encompassed by a round sidewall  93 , has a soft silica gel layer  94 , which wraps over the top surface  91  and sidewall  93 , and a latching jut brim  95  outwardly hooped over the soft silica gel layer  94  on the sidewall  93 . 
         [0080]    Because all the assembling and filling steps as well as the procedure steps in hypodermic injection for all second through seventh exemplary embodiments of the present invention are essentially same as those depicted for the first exemplary embodiments, no extra redundant description are necessary to present here. However, by providing an additional third holding compartment  84  in the middle third vessel  80  for containing third liquid injection medicament R 4 , three different liquid injection medicaments R can be separately filled in the same injection vial with only single set of conventional septum stopper  20  and crimp cap  30  to achieve expected packaging effect so that not only the demanding quantity of the septum stopper  20  and crimp cap  30  can be economically saved, but also the burden for environmental protection in the wasted septum stopper  20  and crimp cap  30  can be reduced.